CHDD
CHDD popup menu
 
chdd logo
Center on Human Development and Disability
About CHDD | IDDRC | UCEDD   

developmental and molecular genetics

Home Page

Collaborative
Research Areas


Research Affiliates

Core Services
Behavioral Science Core

Brain Imaging Core

Cellular Morphology Core

Genetics Core

Animal Behavior Core

Instrument Development Laboratory Core

CHDD Research Domain:
Developmental and Molecular Genetics

Genetic factors account for a significant portion of developmental disabilities. Even milder forms of developmental disability are increasingly known to have a genetic basis. Although much progress has been made in tracking genes responsible for various developmental disabilities, much more knowledge is needed in order to prevent and treat genetically related problems associated with a wide variety of disorders. CHDD researchers are identifying genes, studying their molecular biology, developing techniques for gene therapy, and evaluating pharmacological intervention targets to specific genetic pathways.

Ongoing studies seek the identity of genes associated with specific disorders including autism, learning disabilities and hereditary neuropathies. Studies of the genetic bases of deafness and epilepsy are also underway.

Studies of gene regulation mechanisms involved in immune response are progressing at CHDD. Infants with immature or failed immune systems are prey to infections that can cause neurological impairment and intellectual and other developmental disabilities. Researchers are investigating the association between abnormal immune system function and abnormal central nervous system function and studying the genetic factors involved.

Research is also focused on understanding the cellular and molecular basis for neonates' susceptibility to infection by intracellular pathogens such as herpes simplex virus, Group B Streptococcus, tuberculosis and Listeria, which can have significant neurologic consequences. The molecular basis for why adult T cells protect against infectious agents more readily than neonatal T cells is also of interest. Researchers studying pediatric AIDS are working to develop therapeutic strategies to prevent the transmission of HIV from mother to fetus.

Research continues on the common elements of various neurodevelopmental disorders, including the hereditary ataxias, caused by gene mutations called trinucleotide repeat expansions, in which symptoms appear earlier and more severely from generation to generation. Researchers are investigating the genetic and epigenetic mechanisms underlying X-linked disorders, including fragile X syndrome, the most common known inherited cause of intellectual and other developmental disabilities. Linkage analysis studies and molecular cloning methods are being used to locate genes that cause a number of inherited neurological disorders, including Charcot-Marie-Tooth neuropathy and Disorders of Hindbrain Development. CHDD researchers are also seeking the genetic bases of various forms of craniofacial malformation and associated developmental problems and investigating the molecular basis of numerous neurodegenerative disorders.

Investigators:


Kristina M. Adams Waldorf, M.D.
206-667-7002
Obstetrics and Gynecology
Robert Andrews, M.D.
206-667-4263
Pediatrics
Thomas Benedetti, M.D.
206-616-3789
Pediatrics
Thomas Bird, M.D.
206-543-2340
Neurology
Zoran Brkanac, M.D.
206-543-9573
Psychiatry and Behavioral Sciences
Jeffrey Chamberlain, Ph.D.
206-685-0964
Neurology, Biochemistry, and Medicine
Timothy C. Cox, Ph.D.
206-685-3412
Pediatrics
Michael Cunningham, M.D., Ph.D.
206-616-5277
Pediatrics
Daniel Doherty, M.D., Ph.D.
206-987-2489
Pediatrics
William B. Dobyns, M.D.
206-884-1025
Pediatrics
Evan Eichler, Ph.D.
206-543-9526
Genome Sciences
Elaine Faustman, Ph.D.
206-685-2269
Environmental and Occupational Health Sciences
Clement Furlong, Ph.D.
206-543-1193
Medicine and Genome Sciences
Stanley Gartler, Ph.D.
206-543-1775
Genetics
Ian Glass, M.D.
206-528-5142
Pediatrics
James Ha, Ph.D.
206-543-2420
Psychology
R. Scott Hansen, Ph.D.
206-543-4184
Medical Genetics
Anne Hing, M.D.
206-616-4668
Pediatrics
Rodney Ho, Ph.D.
206-543-9434
Pharmaceutics
Marshall S. Horwitz, M.D., Ph.D.
206-616-4566
Genome Sciences
Cliff Hume, M.D., Ph.D.
206-543-5230
Otolaryngology/Head and Neck Surgery
Charles Laird, Ph.D.
206-616-6267
Zoology
Heather Mefford, M.D., Ph.D.
206-543-9572
Pediatrics
Kathleen J. Millen, Ph.D.
206-884-3225
Pediatrics
David Morris, Ph.D.
206-543-1694
Biochemistry
Hans Ochs, M.D.
206-543-3207
Pediatrics
Leo Pallanck, Ph.D.
206-616-5997
Genome Sciences
Wendy Raskind, M.D., Ph.D.
206-543-3177
Medicine
Craig Rubens, M.D., Ph.D.
206-987-2073
Pediatrics
C. Ronald Scott, M.D.
206-543-3370
Pediatrics
Stephen Tapscott, Ph.D.
206-667-4499
Neurology
Bruce Tempel, Ph.D.
206-616-4693
Otolaryngology/Head and Neck Surgery, Pharmacology
Eric Turner, M.D., Ph.D.
206-884-1025
Integrative Brain Research
Jashvant Unadkat, Ph.D.
206-543-9434
Pharmaceutics
Ellen M. Wijsman, Ph.D.
206-543-8987
Medicine, Biostatistics

University of Washington • Center on Human Development and Disability Box 357920 • Seattle WA 98195-7920 USA • 206-543-7701 • chdd@uw.edu